A PHASE IV OPEN-LABEL CLINICAL TRIAL TO EVALUATE THE EFFICACY OF IKERVIS ON CLINICAL PARAMETERS AND MOLECULAR/CELLULAR BIOMARKERS IN DRY PATIENTS WITH SEVERE DERATITIS WHO HAVE NOT IMPROVED DESPITE REGULAR USE OF TEAR SUBSTITUTES BEFORE AND AFTER EXPOSURE TO AN ADVERSE CONTROLLED ENVIRONMENT. . Equipo personal investigador: CALONGE CANO, MARGARITA (IP); BLAZQUEZ ARAUZO, FRANCISCO; GONZÁLEZ-GARCÍA, MARÍA J.; FERNANDEZ MARTINEZ, ITZIAR; PINTO FRAGA, FRANCISCO JOSE; ENRIQUEZ DE SALAMANCA ALADRO, AMALIA; GARCIA VAZQUEZ, MARIA DEL CARMEN; HERRERAS CANTALAPIEDRA, JOSE MARIA; LOPEZ MIGUEL, ALBERTO; VALENCIA NIETO, LAURA; BLANCO VAZQUEZ, MARTA; ARLANZON LOPE, PABLO. Entidades Participantes: FUNDACION GENERAL DE LA UNIVERSIDAD DE VALLADOLID.. Entidades Financiadoras: SANTEN SA.. 29/04/2019
|